Male contraceptive: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{malaise}} | |||
{{CMG}} | |||
==[[Toxic epidermal necrolysis overview|Overview]]== | ==[[Toxic epidermal necrolysis overview|Overview]]== | ||
Revision as of 18:19, 3 April 2013
Malaise Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Male contraceptive On the Web |
American Roentgen Ray Society Images of Male contraceptive |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Toxic Epidermal Necrolysis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
References
Related Chapters
- Male Contraception Information Project
- UCSB's Sex Info page on male contraception
- MaleContraceptives.org has a summary of experimental male contraceptive methods.
- Male contraceptive trial has 100% success in New Scientist, 6 October 2003.